These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23555646)

  • 1. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
    DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
    PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
    Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
    Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen activity against Plasmodium in vitro and in mice.
    Weinstock A; Gallego-Delgado J; Gomes C; Sherman J; Nikain C; Gonzalez S; Fisher E; Rodriguez A
    Malar J; 2019 Nov; 18(1):378. PubMed ID: 31775753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocaglates as dual-targeting agents for experimental cerebral malaria.
    Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria.
    DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA
    Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
    Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisone effective against murine cerebral malaria.
    Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
    Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
    Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
    Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.
    Ariefta NR; Kume A; Nishikawa Y; Taniguchi T; Umemiya-Shirafuji R; Kasai S; Suzuki H
    Acta Parasitol; 2022 Dec; 67(4):1514-1520. PubMed ID: 35951222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B; Folb P; Ryffel B
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
    Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
    Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria.
    O'Regan N; Moxon C; Gegenbauer K; O'Sullivan JM; Chion A; Smith OP; Preston RJ; Brophy TM; Craig AG; O'Donnell JS
    Thromb Haemost; 2016 Apr; 115(4):773-80. PubMed ID: 26766771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.
    Hempel C; Hoyer N; Staalsø T; Kurtzhals JA
    Malar J; 2014 May; 13():201. PubMed ID: 24885283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S1P is associated with protection in human and experimental cerebral malaria.
    Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
    Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
    Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
    Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel carbon monoxide-releasing molecule fully protects mice from severe malaria.
    Pena AC; Penacho N; Mancio-Silva L; Neres R; Seixas JD; Fernandes AC; Romão CC; Mota MM; Bernardes GJ; Pamplona A
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1281-90. PubMed ID: 22155828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.